Back in the heady days of 2021, Heartcore Capital planned to focus on consumer technology with a $200 million fund. Fast-forward to 2024, and its latest fund will now ‘leaven the bread’ of that thesis, with a fresh $180 million (€170M) to go broader and more generalist than that earlier thesis. Some 17-years into the […]
Although heart disease is the leading cause of death in the United States, a significant portion of people who experience heart attacks are unaware that they have the underlying condition. Cleerly, a cardiovascular imaging startup, hopes to fix this. By analyzing CT scans of the heart, the company’s AI software aims to identify early stage
Cleerly raises $106M from Insight Partners for AI heart health early detection Read More »
Cancer incidence is on the rise, particularly among younger adults, but most new drug compounds fail to progress through clinical trials. According to French entrepreneur Fanny Jaulin (on the right in the picture above), the problem lies with clinical trial design. “Just because a drug isn’t successful in clinical trials doesn’t mean it’s not a
Orakl Oncology combines data and biology to bring new drugs to cancer patients Read More »
Using AI to accelerate biotech is fast becoming standard practice, and companies offering services to deploy the tech quickly are seeing big uptake and new investment. Cradle is one of these, focused on protein design — and it just raised $73 million to build out its labs and team. Cradle appeared in 2022 as part
Cradle builds out its protein-design AI platform (and wet lab) with $73M in new funding Read More »
Writing the documentation that must go alongside the development of new drugs is a highly labor-intensive process: not much software is used and there’s a shortage of expert writers. Paris-based Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing. It’s now raised €6 million
Biolevate’s raises €6M to helps medical writers keep up with the pace of new drugs Read More »
The AI race is taking a detour as developers consider a new path to super-intelligent systems: test-time compute. Not sure what that means? Don’t worry, the Equity pod team breaks it down. Today, on TechCrunch’s Equity podcast, hosts Kirsten Korosec, Devin Coldewey and Margaux MacColl dig into the week’s tech and startup news, including what
The AI industry’s ‘next big bet,’ and should we just buy Chrome? Read More »
Cancer, one of the most life-threatening diseases, is projected to affect over 35 million people worldwide in 2050 — 77% more than the estimated 20 million cases in 2022, according to the World Health Organization. Cancer survivors globally reached 53.5 million, and the reoccurrence rate of the disease varies between 15 and 100%, depending on
OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI Read More »
Cancer, one of the most life-threatening diseases, is projected to affect over 35 million people worldwide in 2050 — 77% more than the estimated 20 million cases in 2022, according to the World Health Organization. Cancer survivors globally reached 53.5 million, and the recurrence rate of the disease varies between 15% and 100%, depending on
OneCell Diagnostics bags $16M to help limit cancer recurrence using AI Read More »
Shiva Suri gained a unique perspective into how radiologists work when he quarantined and shared a home office with his mom, a well-regarded radiologist. “I watched her work day in and day out, and she was wasting about seven to eight hours on boring workflow tasks,” Suri said. “Only 5% of her time, she had
Benchmark invests $19M in New Lantern, a smarter way for radiologists to use AI Read More »
AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it’s never quite as straightforward to implement as one would like. Converge Bio has built a tool for companies to make their biology-focused LLMs actually work, from “enriching” their data to explaining their answers. The company has raised
Converge Bio’s ‘everything store’ for biotech LLMs brings in $5.5M seed Read More »
